Lee Charles T, Strauss David M, Stone Lauren E, Stoltzfus Jill C, Puc Matthew M, Burfeind William R
Department of Surgery, St. Luke's University Health Network, Bethlehem, Pennsylvania, United States.
Department of Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania, United States.
Thorac Cardiovasc Surg. 2019 Mar;67(2):125-130. doi: 10.1055/s-0038-1675638. Epub 2018 Nov 28.
Postoperative atrial fibrillation (POAF) affects 10 to 20% of noncardiac thoracic surgeries and increases patient morbidity and costs. The purpose of this study is to determine if preoperative CHADS-VASc score can predict POAF after pulmonary lobectomy for nonsmall cell lung cancer.
Patients with complete CHADS-VASc data who underwent lobectomies from January 2007 to January 2016 at a single institution were analyzed in a retrospective case-control study using a prospective database. An independent samples -test was used to compare the mean CHADS-VASc scores of POAF and non-POAF groups. A multivariable logistic regression analysis (MVA) evaluated the independent contribution of variables of the CHADS-VASc score in predicting POAF. Chi-square test with univariate odds ratios (ORs) was used to determine a statistically significant cutoff score for predicting POAF.
Of 525 total patients, 82 (15.6%) developed POAF (mean CHADS-VASc score: 2.7) and 443 (84.4%) did not develop POAF (mean score: 2.3). Mean difference between these groups was significant at 0.43 ( = 0.01; 95% confidence interval [CI]: 0.09-0.76). In the MVA, significant predictors of POAF were age 65 to 74 years (adjusted OR [aOR] = 2.45; 95% CI: 1.31-4.70; = 0.006) and age ≥75 years (aOR = 3.11; 95% CI: 1.62-5.95; = 0.0006). Patients with CHADS-VASc scores ≥5 had significantly increased OR for POAF (OR = 2.59; 95% CI: 1.22-5.50).
Preoperatively calculated CHADS-VASc score can predict POAF in patients undergoing pulmonary lobectomy. Age is the most statistically significant independent predictor, and patients with scores ≥5 have significantly increased risk. Trials for POAF prophylaxis should target this population.
术后房颤(POAF)影响10%至20%的非心脏胸科手术患者,增加了患者的发病率和费用。本研究的目的是确定术前CHADS-VASc评分是否可以预测非小细胞肺癌肺叶切除术后的POAF。
对2007年1月至2016年1月在单一机构接受肺叶切除术且有完整CHADS-VASc数据的患者,使用前瞻性数据库进行回顾性病例对照研究分析。采用独立样本t检验比较POAF组和非POAF组的平均CHADS-VASc评分。多变量逻辑回归分析(MVA)评估CHADS-VASc评分变量在预测POAF中的独立贡献。使用单变量比值比(OR)的卡方检验来确定预测POAF的统计学显著临界值。
在525例患者中,82例(15.6%)发生POAF(平均CHADS-VASc评分:2.7),443例(84.4%)未发生POAF(平均评分:2.3)。两组之间的平均差异为0.43,具有显著性(P = 0.01;95%置信区间[CI]:0.09 - 0.76)。在MVA中,POAF的显著预测因素为年龄65至74岁(调整后OR[aOR] = 2.45;95%CI:1.31 - 4.70;P = 0.006)和年龄≥75岁(aOR = 3.11;95%CI:1.62 - 5.95;P = 0.0006)。CHADS-VASc评分≥5的患者发生POAF的OR显著增加(OR = 2.59;95%CI:1.22 - 5.50)。
术前计算的CHADS-VASc评分可以预测肺叶切除患者的POAF。年龄是最具统计学意义的独立预测因素,评分≥5的患者风险显著增加。POAF预防试验应针对这一人群。